Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection

Journal of Virology

Volumn 72, Issue 7, 1998, Pages 5535-5544

  Billstrom, Marcella A ^a,b   Johnson, Gary L ^a,b   Avdi, Natalie J ^c   Worthen, G Scott ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN G; PROTEIN US28; RANTES; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; CYTOMEGALOVIRUS INFECTION; DESENSITIZATION; DISEASE MODEL; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031776873     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.7.5535-5544.1998     Document Type: Article

References (48)

1. 3H]-arachidonic acid prelabelled cells. Arch Virol. 113:255-266.
2. Albrecht, T., I. Boldogh, and M. Fons. 1992. Receptor-initiated activation of cells and their oncogenes by herpes-family viruses. J. Invest. Dermatol. 98: 29S-35S.
3. Albrecht, T., I. Boldogh, M. Fons, S. AbuBakar, and C. Deng. 1990. Cell activation signals and the pathogenesis of HCMV. Intervirology 31:68-75.
4. Albrecht, T., I. Boldogh, M. Fons, C. Lee, S. AbuBakar, J. Russell, and W. Au. 1989. Cell-activation responses to CMV infection. Relationship to phasing of CMV replication and to the induction of cellular damage. Subcell. Biochem. 15:157-202.
5. Avdi, N., B. W. Winston, M. Russel, S. K. Young, G. L. Johnson, and G. S. Worthen. 1996. Activation of MEKK by FMLP in human neutrophils: mapping pathways for MAP kinase activation. J. Biol. Chem. 271:33598-33606.
6. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:97-179.
7. Bando, K., I. Paradis, S. Similo, H. Konishi, K. Komatsu, T. Zullo, S. Yousem, J. Close, A. Zeevi, R. Duquesnoy, et al. 1995. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J. Thorac. Cardiovasc. Surg. 110:4-13.
8. Boldogh, I., S. AbuBakar, C. Deng, and T. Albrecht. 1991. Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J. Virol. 65:1568-1571.
9. Boldogh, I., S. Abubakar, M. Fons, C. Deng, and T. Albrecht. 1991. Activation of cellular oncogenes by clinical isolates and laboratory strains of HCMV. J. Med. Virol. 34:241-247.
10. Buhl, A., N. Avdi, G. Worthen, and G. Johnson. 1994. Mapping of the C5a receptor signal transduction network in human neutrophils. Proc. Natl. Acad. Sci. USA 91:9190-9194.
11. Buhl, A., B. Eisfelder, G. Worthen, G. Johnson, and M. Russell. 1993. Selective coupling of the human anaphylatoxin C5a receptor and α16 in human kidney 293 cells. FEBS Lett. 323:132-134.
12. Chee, M., S. Satchwell, E. Preddie, K. Weston, and B. Barrell. 1990. Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 344:774-777.
13. Egan, S., and R. Weinberg. 1993. The pathway to signal achievement. Nature 365:781-783.
14. Ettinger, N., T. Bailey, E. Trulock, G. Storch, D. anderson, S. Raab, E. Spitznagel, C. Dresler, and J. Cooper. 1993. Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Am. Rev. Respir. Dis. 147:1017-1023.
15. Fish, K., A. Depto, A. Moses, W. Britt, and J. Nelson. 1995. Growth kinetics of HCMV are altered in monocyte-derived macrophages. J. Virol. 69:3737-3743.
16. Friedman, H., E. Macarak, R. MacGregor, J. Wolfe, and N. Kefalides. 1981. Virus infection of endothelial cells. J. Infect. Dis. 143:266-273.
17. Gao, J.-L., and P. Murphy. 1994. Human Cytomegalovirus open reading frame US28 encodes a functional ß-chemokine receptor. J. Biol. Chem. 269: 28539-28542.
18. Gerard, N., and C. Gerard. 1991. The chemoattractant receptor for human C5a anaphylatoxin. Nature 349:614-616.
19. Gimbrone, M., Jr., E. Shefton, and S. Cruise. 1978. Isolation and primary culture of endothelial cells from human umbilical vessels. Tissue Cult. Assoc. Manual 4:813.
20. Grattan, M., C. Moreno-Cabral, V. Starnes, P. Oyer, E. Stinson, and N. Shumway. 1989. CMV infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566.
21. Holmes, W., J. Lee, W. Kuang, G. Rice, and W. Wood. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253:16275-16278.
22. Knall, C., S. Young, J. Nick, A. Buhl, and G. Worthen. 1996. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem. 271:2832-2838.
23. Koskinen, P., M. Nieminen, S. Mattila, P. Hayry, and I. Lautenschlager. 1993. The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients. Transplantation 55:547-551.
24. Kuhn, D., C. Beall, and P. Kolattukudy. 1995. The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem. Biophys. Res. Commun. 211:325-330.
25. Lu, Z., Z. Wang, R. Horuk, J. Hellelgesser, Y. Lou, T. Hadley, and S. Peiper. 1995. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J. Biol. Chem. 270:26239-26245.
26. Marshall, C. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
27. McColl, S., M. Hachicha, S. Levasseur, K. Neote, and T. Schall. 1993. Uncoupling of early signal transduction events from effector function in human peripheral blood neutrophils in response to recombinant MIP-1α and 1β. J. Immunol. 150:4550-4560.
28. Melnick, J., E. Adam, and M. DeBakey. 1990. Possible role of CMV in atherogenesis. JAMA 263:2204-2207.
29. Neote, K., D. DiGregorio, J. Mak, R. Horuk, and T. Schall. 1993. Molecular cloning, functional expression and signaling characteristics of a CC chemokine receptor. Cell 72:415-425.
30. Neote, K., J. Mak, L. K. Jr., and T. Schall. 1994. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 84:44-52.
31. Nick, J., N. Avdi, P. Gerwins, G. Johnson, and G. Worthen. 1996. Activation of a p38 mitogen-activated protein kinase in human neutrophils by LPS. J. Immunol. 156:4867-4875.
32. 2+ responses in CMV-infected fibroblasts of human origin. Virology 157:259-267.
33. Okazaki, K. and N. Sagata. 1995. The MOS/MAP kinase pathway stabilizes c-fox by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14:5048-5059.
34. Opdenakker, G., G. Froyen, P. Fiten, P. Proost, and J. VanDamme. 1993. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Biochem. Biophys. Res. Commun. 191:535-542.
35. Peiper, S., T., Wang, K. Neote, A. Martin, H. Showell, M. Conklyn, K. Ogborne, T. Hadley, Z. Lu, and J. Hesselgesser. 1995. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J. Exp. Med. 181:1311-1317.
36. Shibutani, T., T. M. Johnson, Z. X. Yu, V. J. Ferrans, J. Moss, and S. E. Epstein. 1997. Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J. Clin. Invest. 100:2054-2061.
37. Sozzani, S., M. Molino, M. Locati, W. Luini, C. Cerletti, A. Vecchi, and A. Mantovani. 1993. Receptor-activated calcium influx in human monocytes exposed to monocyte chemotactic protein-1 and related cytokines. J. Immunol. 150:1544-1553.
38. Sozzani, S., F. Sallusto, W. Luini, D. Zhou, L. Piemonti, P. Allavena, J. V. Damme, S. Valitutti, A. Lanzavecchia, and A. Mantovani. 1995. Migration of dendritic cells in response to formyl peptides, C5a and a distinct set of chemokines. J. Immunol. 155:3292-3295.
39. Sozzani, S., D. Zhou, M. Locati, M. Rieppi, P. Proost, M. Magazin, N. Vita, J. V. Damme, and A. Mantovani. 1994. Receptors and transduction pathways for monocyte chemotactic protein-2 and MCP-3. J. Immunol. 152:3615-3622.
40. Sozzani, S., D. Zhou, M. Locati, M. Rieppi, P. Proost, M. Magazin, N. Vita, J. V. Damme, and A. Mantovani. 1994. Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3: similarities and differences with MCP-1. J. Immunol. 152:3615.
41. Span, A., M. V. Dam-Mieras, W. Mullers, J. Endert, A. Muller, and C. Bruggeman. 1991. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur. J. Clin. Invest. 21:331-338.
42. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α, MIP-1β on human monocytes. Eur. J. Immunol. 25:64-68.
43. Valyi-Nagy, T., Z. Bandi, I. Boldogh, and T. Albrecht. 1988. Hydrolysis of inositol lipids: an early signal of HCMV infection. Arch. Virol. 101:199-207.
44. VanDamme, J., P. Proost, J. Lenaerts, and G. Opedenakker. 1992. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176:59.
45. von Laer, D., A. Serr, U. Meyer-Konig, G. Kirste, F. Hufert, and O. Haller. 1995. Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo. J. Infect. Dis. 172:365-370.
46. Waldman, W., W. Roberts, D. Davis, M. Williams, D. Sedmak, and R. Stephens. 1991. Preservation of natural endothelial cytopathogenicity of CMV by propagation in endothelial cells. Arch. Virol. 117:143-164.
47. Worthen, G., N. Avdi, A. Buhl, N. Suzuki, and G. Johnson. 1994. fMLP activates Ras and Raf in human neutrophils. J. Clin. Invest. 94:815-823.
48. Xu, L., D. McVica, A. Ben-Baruch, D. Kuhns, J. Johnston, J. Oppenheim, and J. Wang. 1995. MCP-3 interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur. J. Immunol. 25:2612-2617.